Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection
This study is currently recruiting participants.
Verified September 2012 by Cedars-Sinai Medical Center
Study NCT01134510   Information provided by Cedars-Sinai Medical Center

First Received on May 26, 2010.   Last Updated on September 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Transplantation
Interventions listed in this trial
C1 Esterase Inhibitor
Additional drug interventions recognized in this trial
Complement C1
Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein
Complement C1s
More general drug interventions related to this trial
Complement Inactivating Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Stanley Jordan, MD
CSL Behring


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services